BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32723198)

  • 1. RNA-sequencing of acute promyelocytic leukemia primary blasts reveals novel molecular biomarkers of early death events.
    Jann JC; Streuer A; Hecht A; Nolte F; Nowak V; Danner J; Obländer J; Palme I; Lengfelder E; Platzbecker U; Hofmann WK; Flach J; Nowak D
    Leuk Lymphoma; 2020 Dec; 61(13):3066-3077. PubMed ID: 32723198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
    Zhao S; Ge Y; Li Z; Yang T
    Front Immunol; 2023; 14():1100151. PubMed ID: 37063881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
    Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
    Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots.
    Kárai B; Habók M; Reményi G; Rejtő L; Ujfalusi A; Kappelmayer J; Hevessy Z
    Ann Hematol; 2019 Jun; 98(6):1413-1420. PubMed ID: 30830246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
    Testa U; Lo-Coco F
    Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
    Zhao J; Liang JW; Xue HL; Shen SH; Chen J; Tang YJ; Yu LS; Liang HH; Gu LJ; Tang JY; Li BS
    Leukemia; 2019 Jun; 33(6):1387-1399. PubMed ID: 30575821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia from acute myeloid leukemia with multiparameter flow cytometry.
    Chen Z; Li Y; Tong Y; Gao Q; Mao X; Zhang W; Xia Z; Fu C
    Int J Hematol; 2016 Mar; 103(3):306-15. PubMed ID: 26759321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptic Acute Promyelocytic Leukemia (APL) Presenting as Seizures in an Adolescent.
    Mai B; Liang C; Nguyen A; Wahed A; Chen L
    Ann Clin Lab Sci; 2020 Mar; 50(2):270-273. PubMed ID: 32366568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling and functional analysis of circular RNAs in acute promyelocytic leukemia and their dynamic regulation during all-trans retinoic acid treatment.
    Li S; Ma Y; Tan Y; Ma X; Zhao M; Chen B; Zhang R; Chen Z; Wang K
    Cell Death Dis; 2018 May; 9(6):651. PubMed ID: 29844435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.
    Callens C; Chevret S; Cayuela JM; Cassinat B; Raffoux E; de Botton S; Thomas X; Guerci A; Fegueux N; Pigneux A; Stoppa AM; Lamy T; Rigal-Huguet F; Vekhoff A; Meyer-Monard S; Ferrand A; Sanz M; Chomienne C; Fenaux P; Dombret H;
    Leukemia; 2005 Jul; 19(7):1153-60. PubMed ID: 15889156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens.
    Hecht A; Doll S; Altmann H; Nowak D; Lengfelder E; Röllig C; Ehninger G; Spiekermann K; Hiddemann W; Weiß C; Hofmann WK; Nolte F; Platzbecker U
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):889-896.e5. PubMed ID: 28923666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin.
    Lavallée VP; Chagraoui J; MacRae T; Marquis M; Bonnefoy A; Krosl J; Lemieux S; Marinier A; Pabst C; Rivard GÉ; Hébert J; Sauvageau G
    Leukemia; 2018 Jun; 32(6):1349-1357. PubMed ID: 29550835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global characteristics of childhood acute promyelocytic leukemia.
    Zhang L; Samad A; Pombo-de-Oliveira MS; Scelo G; Smith MT; Feusner J; Wiemels JL; Metayer C
    Blood Rev; 2015 Mar; 29(2):101-25. PubMed ID: 25445717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia.
    Zhao H; Zhao Y; Zhang Y; Hou J; Yang H; Cao F; Yang Y; Hou W; Sun J; Jin B; Fu J; Li H; Wang P; Ge F; Zhou J
    Ann Hematol; 2018 Mar; 97(3):409-416. PubMed ID: 29289982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of a new six-panel flow cytometry marker for early differential diagnosis of APL from HLA-DR negative Non-APL leukemia.
    Mosleh M; Mehrpouri M; Ghaffari S; Saei Z; Agaeipoor M; Jadali F; Satlsar ES; Gholampour R
    Scand J Clin Lab Invest; 2020; 80(2):87-92. PubMed ID: 31829759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute promyelocytic leukemia and variant fusion proteins: PLZF-RARα fusion protein at a glance.
    Hussain L; Maimaitiyiming Y; Islam K; Naranmandura H
    Semin Oncol; 2019 Apr; 46(2):133-144. PubMed ID: 31126665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global problem of early deaths in acute promyelocytic leukemia: A strategy to decrease induction mortality in the most curable leukemia.
    Jillella AP; Kota VK
    Blood Rev; 2018 Mar; 32(2):89-95. PubMed ID: 29033137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy.
    Abla O; Ribeiro RC; Testi AM; Montesinos P; Creutzig U; Sung L; Di Giuseppe G; Stephens D; Feusner JH; Powell BL; Hasle H; Kaspers GJL; Dalla-Pozza L; Lassaletta A; Tallman MS; Locatelli F; Reinhardt D; Lo-Coco F; Hitzler J; Sanz MA
    Ann Hematol; 2017 Sep; 96(9):1449-1456. PubMed ID: 28597167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing the room for improvement in management of acute promyelocytic leukemia.
    Nørgaard JM; Friis LS; Kristensen JS; Severinsen MT; Mølle I; Marcher CW; Møller P; Schoellkopf C; Nielsen OJ; Preiss BS; Andersen MK; Kjeldsen E; Medeiros BC; Østgård LSG;
    Eur J Haematol; 2019 Jun; 102(6):479-485. PubMed ID: 30887583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcome of childhood acute promyelocitic leukemia (APL) in Saudi Arabia: a multicenter SAPHOS leukemia group study.
    Jastaniah W; Alsultan A; Al Daama S; Ballourah W; Bayoumy M; Al-Anzi F; Al Shareef O; Abrar MB; Al Sudairy R; Al Ghemlas I
    Hematology; 2018 Jul; 23(6):316-323. PubMed ID: 29212418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.